Mode
Text Size
Log in / Sign up
Phase 2 N=73 Treatment

The Alberta Diet: Effectiveness Study

Type 2 Diabetes

Enrolled (actual)
73
Serious AEs
Results posted
Aug 2015
Primary outcome: Primary: Change in Total Energy Intake — -178 kcal

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
PANDA intervention (Behavioral)
Age
Adult, Older Adult · 35+ yrs
Sex
All
Sponsor
University of Alberta
Primary completion
Oct 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Total Energy Intake
-178
PRIMARY
Change in Macronutrient Intake
-1; 0; 0; 2; 0
PRIMARY
Change in Nutrient Intake
-10; -3; -3; 0; -6; -12
SECONDARY
Change in Hemoglobin A1c
-0.7
SECONDARY
Program Retention
63
SECONDARY
Change in Body Mass Index
-0.6
SECONDARY
Body Composition
-0.8; 0.8
SECONDARY
Change in Blood Biomarkers
-63.5; 27.5; -88.9; -10.4
SECONDARY
Change in Perceived Dietary Adherence Questionnaire Score
9.3
SECONDARY
Food Acceptability
SECONDARY
Food Accessibility
SECONDARY
Food Availability
SECONDARY
Change in Waist Circumference
-2.4

Summary

The study hypothesis is that individuals with type 2 diabetes (T2D), who adhere to the PANDA intervention, will have improved compliance with the nutritional therapy recommendations of the Canadian Diabetes Association. Specific objectives of this proposal: The objectives of the investigators PANDA (Physical Activity and Nutrition for Diabetes in Alberta) are to (a) to devise and evaluate the efficacy of a multi-level, practical, nutrition intervention program that promotes the individual factors required for effective self-management practices AND that explicitly incorporate strategies to improve food availability, accessibility and acceptability and (b) to use these interventions as a means to examine the relationships between food availability, accessibility, acceptability, adherence to Nutrition Therapy Guidelines, and metabolic indicators of diabetes control in people with type 2 diabetes.

Eligibility Criteria

Inclusion Criteria

  • Type 2 diabetes, and speak/write English.
  • Have attended a diabetes education session delivered by their healthcare provider.

Exclusion Criteria

  • Participants with type 1 diabetes, and those who are unable to speak English.
  • People with end-stage renal disease or gastrointestinal diseases that require specialized diets will also be excluded.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01625507). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search